Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout.

PubWeight™: 2.84‹?› | Rank: Top 1%

🔗 View Article (PMID 4884382)

Published in Ann Intern Med on January 01, 1969

Authors

W N Kelley, M L Greene, F M Rosenbloom, J F Henderson, J E Seegmiller

Articles citing this

Attenuated variants of Lesch-Nyhan disease. Brain (2010) 2.80

The organization of the human HPRT gene. Nucleic Acids Res (1986) 1.75

Human hypoxanthine-guanine phosphoribosyltransferase. Demonstration of structural variants in lymphoblastoid cells derived from patients with a deficiency of the enzyme. J Clin Invest (1982) 1.65

Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet J Rare Dis (2007) 1.48

Hypoxanthine-guanine phosphoribosyltransferase deficiency: activity in normal, mutant, and heterozygote-cultured human skin fibroblasts. Proc Natl Acad Sci U S A (1970) 1.42

A molecular survey of hypoxanthine-guanine phosphoribosyltransferase deficiency in man. J Clin Invest (1986) 1.28

Expression of purine overproduction in a series of 8-azaguanine-resistant diploid human lymphoblast lines. Proc Natl Acad Sci U S A (1974) 1.25

Clinical pharmacology. Possible clinical importance of genetic differences in drug metabolism. Br Med J (Clin Res Ed) (1981) 1.24

Hypoxanthine-guanine phosphoribosyltransferase: characteristics of the mutant enzyme in erythrocytes from patients with the Lesch-Nyhan syndrome. J Clin Invest (1972) 1.21

Update on the phenotypic spectrum of Lesch-Nyhan disease and its attenuated variants. Curr Rheumatol Rep (2012) 1.16

X-chromosome inactivation and the Xg locus. Am J Hum Genet (1970) 1.15

Variant human phosphoribosylpyrophosphate synthetase altered in regulatory and catalytic functions. J Clin Invest (1980) 1.04

Activation of variants of hypoxanthine-guanine phosphoribosyl transferase by the normal enzyme. Proc Natl Acad Sci U S A (1972) 1.04

High level expression in Escherichia coli of soluble, enzymatically active schistosomal hypoxanthine/guanine phosphoribosyltransferase and trypanosomal ornithine decarboxylase. Proc Natl Acad Sci U S A (1991) 1.04

Analysis of abnormalities in purine metabolism leading to gout and to neurological dysfunctions in man. Biochem J (1998) 1.04

Gout and its relation to lipid metabolism. I. Serum uric acid, lipid, and lipoprotein levels in gout. Ann Rheum Dis (1973) 1.03

Mechanism of excessive purine biosynthesis in hypoxanthine-guanine phosphoribosyltransferase deficiency. J Clin Invest (1970) 1.02

Severe gouty arthritis and mild neurologic symptoms due to F199C, a newly identified variant of the hypoxanthine guanine phosphoribosyltransferase. Arthritis Rheum (2009) 1.02

Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction. J Clin Invest (1976) 1.00

Disparate enzyme activity in erythocytes and leukocytes. A variant of hypoxanthine phosphoribosyl-transferase deficiency with an unstable enzyme. J Clin Invest (1973) 0.99

Yeast GMP kinase mutants constitutively express AMP biosynthesis genes by phenocopying a hypoxanthine-guanine phosphoribosyltransferase defect. Genetics (2000) 0.96

Hereditary xanthinuria. Evidence for enhanced hypoxanthine salvage. J Clin Invest (1987) 0.95

ASCI: reflections on the first 100 years and a proposal for the next. J Clin Invest (2008) 0.95

Protein variations associated with Lesch-Nyhan syndrome. Proc Natl Acad Sci U S A (1981) 0.95

Linkage relationships of X-linked enzymes glucose-6-phosphate dehydrogenase and hypoxanthine guanine phosphoribosyltransferase: recombination in female offspring of compound heterozygotes. Am J Hum Genet (1974) 0.93

Hypoxanthine phosphoribosyltransferase activity in intact fibroblasts from patients with X-linked hyperuricemia. J Clin Invest (1976) 0.91

Ternary complex structure of human HGPRTase, PRPP, Mg2+, and the inhibitor HPP reveals the involvement of the flexible loop in substrate binding. Protein Sci (1999) 0.91

Hypoxanthine-guanine phosphoribosyltransferase. Characterization of a mutant in a patient with gout. J Clin Invest (1975) 0.90

Purine oversecretion in cultured murine lymphoma cells deficient in adenylosuccinate synthetase: genetic model for inherited hyperuricemia and gout. Proc Natl Acad Sci U S A (1982) 0.88

Clinical and biochemical observations on three cases of hypoxanthine-guanine phosphoribosyltransferase deficiency. Ann Rheum Dis (1975) 0.87

Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency. Contribution by impaired purine salvage. J Clin Invest (1979) 0.87

Analysis of cDNA encoding the hypoxanthine-guanine phosphoribosyltransferase (HGPRTase) of Schistosoma mansoni; a putative target for chemotherapy. Nucleic Acids Res (1988) 0.86

The kinetics of intramolecular distribution of 15N in uric acid after administration of (15N) glycine. A reappraisal of the significance of preferential labeling of N-(3+9) of uric acid in primary gout. J Clin Invest (1973) 0.86

Hypoxanthine-guanine phosphoribosyltransferase deficiency and Xg blood group. Am J Hum Genet (1970) 0.86

Genetic studies on the role of the nucleoside transport function in nucleoside efflux, the inosine cycle, and purine biosynthesis. Mol Cell Biol (1983) 0.86

Diaminopurine-resistant mutants of cultured, diploid human fibroblasts. Genetics (1973) 0.84

Genotypic and phenotypic spectrum in attenuated variants of Lesch-Nyhan disease. Mol Genet Metab (2014) 0.83

Heberden oration 1979: human aberrations of purine metabolism and their significance for rheumatology. Ann Rheum Dis (1980) 0.82

Hypoxanthine-guanine phosphoribosyltransferase variant associated with accelerated purine synthesis. J Clin Invest (1973) 0.82

Purine metabolism in normal and thioguanine-resistant neuroblastoma. Proc Natl Acad Sci U S A (1973) 0.82

Lesch-Nyhan Syndrome: Models, Theories, and Therapies. Mol Syndromol (2016) 0.82

Use of phytohaemagglutinin stimulated lymphocytes to study effects of hypoxanthine-guanine phosphoribosyltransferase (HGPRT) deficiency on polynucleotide and protein synthesis in the Lesch-Nyhan syndrome. J Med Genet (1976) 0.80

Clinical and biochemical studies on treatment of Lesch-Nyhan syndrome. Arch Dis Child (1974) 0.80

Molecular variation in relation to purine metabolism. J Clin Pathol Suppl (R Coll Pathol) (1974) 0.78

Comparative complement selection in bacteria enables screening for lead compounds targeted to a purine salvage enzyme of parasites. Antimicrob Agents Chemother (1995) 0.78

Evidence for a class of very small introns in the gene for hypoxanthine-guanine phosphoribosyltransferase in Schistosoma mansoni. Nucleic Acids Res (1989) 0.77

Unbalanced deoxyribonucleotide synthesis caused by methotrexate. Br Med J (1972) 0.77

The Jeremiah Metzger lecture. Current status of human gene therapy. Trans Am Clin Climatol Assoc (1988) 0.76

A reappraisal of the concept of an abnormality of glutamine metabolism in primary gout. Trans Am Clin Climatol Assoc (1973) 0.75

Genetics and clinical enzymology. J Clin Pathol Suppl (Assoc Clin Pathol) (1970) 0.75

Pathophysiology of hyperuricemia in primary gout. Trans Am Clin Climatol Assoc (1970) 0.75

Kidney stones. West J Med (1980) 0.75

Gout and neurological abnormalities associated with cardiomyopathy in a young man. Ann Rheum Dis (1990) 0.75

Human hypoxanthine-guanine phosphoribosyltransferase: studies of the normal and five mutant forms of the enzyme. Trans Am Clin Climatol Assoc (1983) 0.75

Juvenile gout. Br Med J (1972) 0.75

A new HGPRT-deficient phenotype? J Med Genet (1972) 0.75

Absence of measurable linkage between the loci for hypoxanthine-guanine phosphoribosyltransferase and deutan colorblindness. Am J Hum Genet (1974) 0.75

Do clinical features of Lesch-Nyhan disease correlate more closely with hypoxanthine or guanine recycling? J Inherit Metab Dis (2015) 0.75

Articles by these authors

Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science (1967) 7.75

A specific enzyme defect in gout associated with overproduction of uric acid. Proc Natl Acad Sci U S A (1967) 3.29

Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s). Proc Natl Acad Sci U S A (1977) 2.90

A possible nucleotide-binding domain in the tertiary fold of phosphoribosyltransferases. J Biol Chem (1983) 2.60

The occurrence of new mutants in the X-linked recessive Lesch-Nyhan disease. Am J Hum Genet (1976) 2.51

The role of adenosine and 2'-deoxyadenosine in mammalian cells. Annu Rev Biochem (1978) 2.49

Human adenosine deaminase. cDNA and complete primary amino acid sequence. J Biol Chem (1984) 2.33

Increased cystine in leukocytes from individuals homozygous and heterozygous for cystinosis. Science (1967) 2.12

Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyltransferase. J Biol Chem (1968) 2.08

Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells. Proc Natl Acad Sci U S A (1978) 1.93

Some biophysical properties of virus present in tissue cultures infected with the nuclear polyhedrosis virus of Trichoplusia ni. J Gen Virol (1974) 1.89

Adenosine kinase initiates the major route of ribavirin activation in a cultured human cell line. Proc Natl Acad Sci U S A (1978) 1.79

Urine uric acid to creatinine rtio--a screening test for inherited disorders of purine metabolism. Phosphoribosyltransferase (PRT) deficiency in X-linked cerebral palsy and in a variant of gout. J Pediatr (1968) 1.76

Morphogenesis of nuclear polyhedrosis virus under conditions of prolonged passage in vitro. J Ultrastruct Res (1974) 1.75

Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines. Proc Natl Acad Sci U S A (1979) 1.72

Hyperuricemia and gout. Classification, complications and management. N Engl J Med (1979) 1.71

Suppression of metabolic accompaniments of phagocytosis by colchicine. Arthritis Rheum (1965) 1.70

Studies on the mechanism of fructose-induced hyperuricemia in man. Metabolism (1972) 1.67

Human hypoxanthine-guanine phosphoribosyltransferase. Demonstration of structural variants in lymphoblastoid cells derived from patients with a deficiency of the enzyme. J Clin Invest (1982) 1.65

Human adenine phosphoribosyltransferase. Identification of allelic mutations at the nucleotide level as a cause of complete deficiency of the enzyme. J Clin Invest (1987) 1.59

Increased free-cystine content of fibroblasts cultured from patients with cystinosis. Biochem Biophys Res Commun (1967) 1.58

An enzymatic spectrophotometric method for the determination of xanthine and hypoxanthine. Clin Chem (1967) 1.57

Lesch-Nyhan syndrome: altered kinetic properties of mutant enzyme. Science (1971) 1.56

Serial passage of a nuclear polyhedrosis disease virus of the cabbage looper (Trichoplusia ni) in a continuous tissue culture cell line. Virology (1972) 1.55

A role for adenosine deaminase in human monocyte maturation. J Clin Invest (1976) 1.55

Human glutamine phosphoribosylpyrophosphate amidotransferase. Kinetic and regulatory properties. J Biol Chem (1973) 1.53

Human adenosine deaminase. Distribution and properties. J Biol Chem (1976) 1.53

Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Engl J Med (1981) 1.48

Evidence for intergenic complementation in hybrid cells derived from two human diploid strains each carrying an X-linked mutation. Proc Natl Acad Sci U S A (1969) 1.48

Measurement of DNA in cultured human cells. Anal Biochem (1974) 1.48

Specificity of adenosine deaminase inhibitors. Biochem Pharmacol (1977) 1.47

Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol. N Engl J Med (1970) 1.46

Urinary xanthine stones--a rare complications of allopurinol therapy. N Engl J Med (1969) 1.45

An enzymatic basis for variation in response to allopurinol. Hypoxanthine-guanine phosphoribosyltransferase deficiency. N Engl J Med (1968) 1.45

Molecular cloning of human adenosine deaminase gene sequences. J Biol Chem (1983) 1.44

Studies on hypoxanthine-guanine phosphoribosyltransferase in fibroblasts from patients with the Lesch-Nyhan syndrome. Evidence for genetic heterogeneity. J Biol Chem (1971) 1.43

Human hypoxanthine-guanine phosphoribosyltransferase. Purification and subunit structure. J Biol Chem (1971) 1.42

Hypoxanthine-guanine phosphoribosyltransferase deficiency: activity in normal, mutant, and heterozygote-cultured human skin fibroblasts. Proc Natl Acad Sci U S A (1970) 1.42

Adenine and adenosine are toxic to human lymphoblast mutants defective in purine salvage enzymes. Science (1977) 1.40

Differential sensitivity of human leukemic T cell lines and B cell lines to growth inhibition by deoxyadenosine. J Immunol (1978) 1.40

Adenosine deaminase deficiency and severe combined immunodeficiency disease. Adv Enzymol Relat Areas Mol Biol (1980) 1.39

Retroviral vector-mediated gene transfer into human hematopoietic progenitor cells. Science (1985) 1.39

The integrated inpatient management model. A new approach to clinical practice. Ann Intern Med (1989) 1.39

Human hypoxanthine (guanine) phosphoribosyltransferase: an amino acid substitution in a mutant form of the enzyme isolated from a patient with gout. Proc Natl Acad Sci U S A (1983) 1.39

Adenine phosphoribosyltransferase deficiency: a previously undescribed genetic defect in man. J Clin Invest (1968) 1.38

Human phosphoribosylpyrophosphate synthetase. Distribution, purification, and properties. J Biol Chem (1971) 1.38

New prospects for understanding and control of genetic diseases. Arch Intern Med (1972) 1.38

Xanthine oxidase activity in human tissues and its inhibition by allopurinol (4-hydroxypyrazolo[3,4-d] pyrimidine). J Lab Clin Med (1965) 1.37

The acute attack of gouty arthritis. Arthritis Rheum (1965) 1.37

Human adenine phosphoribosyltransferase deficiency. Demonstration of a single mutant allele common to the Japanese. J Clin Invest (1988) 1.36

The presence of a kinin in inflammatory synovial effusion from arthritides of varying etiologies. Arthritis Rheum (1967) 1.36

Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis. J Clin Invest (1976) 1.36

Human phosphoribosylpyrophosphate synthetase. Kinetic mechanism and end product inhibition. J Biol Chem (1972) 1.36

Human adenosine deaminase. Purification and subunit structure. J Biol Chem (1977) 1.35

Transient expression of human adenosine deaminase cDNAs: identification of a nonfunctional clone resulting from a single amino acid substitution. Mol Cell Biol (1985) 1.35

Inherited disorder of purine metabolism. Correlation between central nervous system dysfunction and biochemical defects. JAMA (1967) 1.34

An enzymatic determination of ammonia in biological fluids. J Lab Clin Med (1965) 1.34

Biochemical diagnosis of an X-linked disease in utero. Lancet (1968) 1.34

Regulation of de novo purine biosynthesis in human lymphoblasts. Coordinate control of proximal (rate-determining) steps and the inosinic acid branch point. J Biol Chem (1976) 1.34

Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci U S A (1998) 1.33

Rate-limiting steps in the interconversion of purine ribonucleotides in Ehrlich ascites tumor cells in vitro. Cancer Res (1971) 1.33

Human hypoxanthine-guanine phosphoribosyltransferase. Complete amino acid sequence of the erythrocyte enzyme. J Biol Chem (1982) 1.33

Human hypoxanthine-guanine phosphoribosyltransferase. Purification and characterization of mutant forms of the enzyme. J Biol Chem (1981) 1.32

Lesch-Nyhan syndrome: preventive control by prenatal diagnosis. Science (1970) 1.31

Altered regulation of Epstein-Barr virus induced lymphoblast proliferation in rheumatoid arthritis lymphoid cells. Arthritis Rheum (1980) 1.31

Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes. J Clin Invest (1976) 1.29

Consequences of inhibition of guanine nucleotide synthesis by mycophenolic acid and virazole. Cancer Res (1977) 1.28

Kinetic studies of hypoxanthine-guanine phosphoribosyltransferase. J Biol Chem (1968) 1.28

Phosphoribosylpyrophosphate in man: biochemical and clinical significance. Ann Intern Med (1971) 1.28

A molecular survey of hypoxanthine-guanine phosphoribosyltransferase deficiency in man. J Clin Invest (1986) 1.28

Alternative pathways of deoxyadenosine and adenosine metabolism. J Biol Chem (1973) 1.27

Cystine: compartmentalization within lysosomes in cystinotic leukocytes. Science (1969) 1.27

Expression of purine overproduction in a series of 8-azaguanine-resistant diploid human lymphoblast lines. Proc Natl Acad Sci U S A (1974) 1.25

Effects of ascorbic acid in alkaptonuria: alterations in benzoquinone acetic acid and an ontogenic effect in infancy. Pediatr Res (1989) 1.25

Stimulation of human purine synthesis de novo by fructose infusion. Metabolism (1975) 1.25

Molecular form of adenosine deaminase in severe combined immunodeficiency. Biochem Biophys Res Commun (1974) 1.24

Human hypoxanthine-guanine phosphoribosyltransferase. Evidence for tetrameric structure. J Biol Chem (1978) 1.24